Healthcare tech company to add 100 jobs following success of AI-powered bot

Danielle Brown | | Health Exec | Artificial Intelligence

After seeing success from its AI-powered healthcare bot, Ohio-based healthcare technology company Olive is planning to add 100 tech jobs within the next two years, according to a report by Columbus Business First.

Olive’s healthcare robot leverages AI to automate repetitive healthcare administrative tasks, like scheduling and checking insurance eligibility. Sales for the company’s robot have topped about $10 million after several large hospitals signed on to use the service, according to the report.

In the spring of 2017, the company had roughly 60 employees and climbed to about 80 by the end of the year. Jobs it plans to add include skilled software and robotic process automation engineers, product management, marketing, sales and customer support.

To read the full report, click the link below.

Olive adding 100 jobs in Columbus as AI bot for healthcare takes off

""
Danielle Brown

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Related Content

To tell or not to tell: Do patients really need to know who—or what—writes their doctor’s notes?
5 ways AI can help make healthcare more affordable for everyone
HIMSS survey report: Beware insider threats to cybersecurity involving AI
Cleerly and Bunkerhill Health unite in the name of AI-based cardiac imaging evaluations
Academic health system working on AI dictation feature for Epic
Primary care is primed for AI. But is AI aligned with primary care?

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.